参考文献/References:
[1] GO A S,MOZAFFARIAN D,ROGER V L,et al.Heart disease and stroke statistics——2014 update:A report from the American heart association[J].Circulation,2014,129(3):e254-e743.
[2] NISHIOKA R,SUGIMOTO K,AONO H,et al.Treadmill exercise ameliorates ischemia-induced brain edema while suppressing Na/H exchanger 1 expression[J].Exp Neurol,2015,52(1):54-60.
[3] 王清任.医林改错(下卷)[M].北京:人民卫生出版社,2005:36.
[4] 蔺桂芬,孙骏奇,常燕来,等.血小板口恶A2的药理学调节-Ⅰ、川芎嗪对血小板A2的生物合成及其生物活性的影响[J].北京第二医院学报,1980,1(1):50-57.
[5] 许世凯.抗衰老药物的药理与应用[M].上海:上海中医学院出版社,1987:141.
[6] 朱建贵.实用延寿中医药[M].北京:北京出版社,1990:155,296.
[7] 郭平,王浩,王晶.补阳还五汤对实验性脑缺血再灌注损伤抗氧化作用的研究[J].山东中医杂志,2001,20(10):621-623.
[8] 李倩宇,卢健棋,温志浩,等.基于PI3K/Akt通路探讨补阳还五汤对急性心肌梗死大鼠内皮祖细胞凋亡的影响[J].陕西中医,2023,44(7):827-832.
[9] 田倩倩,刘建春,王晓庆,等.补阳还五汤抗炎作用研究进展[J].中华中医药学刊,2017,35(4):876-878.
[10] 高剑峰,王晓辉,刘轲,等.补阳还五汤对老龄大鼠脑缺血再灌注脑组织 TNF-α、ICAM-1 和 VCAM-1表达变化的影响[J].北京中医药大学学报(中医临床版),2008,15(4):1-4.
[11] SENGER G R,DAVIS G E.Angiogenesis[J].Cold Spring Harb Perspect Biol,2011,3(8):50-59.
[12] WEI R L,TENG H J,YIN B,et al.A systematic review and meta-analysis of Buyang Huanwu decoction in animal model of focal cerebral ischemia[J].Evid Based Colement Alternat Med,2013,54(1):157-160.
[13] CUI H J,YANG A L,ZHOU H J,et al.Buyang Huanwu decoction promotes angiogenesis via vascular endothelial growth factor receptor-2 activation through the PI3K/Akt pathway in a mouse model of intracerebral hemorrhage[J].BMC Complement Altern Med,2015,15(1):91.
[14] HIMANGSHU S,KIRTIKAR S,SUMEDHA K,et al.Vialinin A an edible mushroom-derived p-terphenyl antioxidant prevents VEGF-induced neovascularization in vitro and in vivo[J].Oxidative Medicine & Cellular Longevity,2018,20(8):1-10.
[15] 王波,徐勇,李祥,等.坏死性凋亡介导化学性缺氧引起的HT22海马神经元损伤和炎症[J].中国药理学通报,2017,33(4):480-486.
[16] CARMELIET P,JAIN R K.Molecular mechanisms and clinical applications of angiogenesis[J].Nature,2011,473(7347):298-307.
[17] LAAKKONEN J P,LAPPALAINEN J P,THEELEN T L,et al.Differential regulation of angiogenic cellular processes and claudin-5 by histamine and VEGF via PI3K-signaling transcription factor SNAI2 and interleukin-8[J].Angiogenesis,2016,20(1):1-16.
[18] CHEN J,GU Z,WU M,et al.C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways[J].Stem Cell Res Ther,2016,7(1):114.
[19] CHEN H,CONG Q,DU Z,et al.Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling[J].Cancer Lett,2016,382(1):44-52.
[20] 朱丽,李静.不同剂量黄芪配伍的补阳还五汤对IS患者血液流变学及疗效的影响[J].陕西中医,2014,35(9):1145-1147.
[21] 唐映红,邓常青,刘旺华,等.补阳还五汤 4 类有效部位对局灶性脑缺血大鼠脑梗死体积的影响[J].中草药,2005,36(2):236-239.
[22] 孙忠,彭康.HPLC-ELSD法测定补阳还五汤中黄芪甲苷含量的研究[J].中医药学刊,2004,22(4):599-600.
[23] 李再新,吴小红,贺福元,等.补阳还五汤中川芎嗪的药代动力学研究[J].中国药业,2007,16(18):23-24.
[24] 张军,陈汀波,陈军,等.HPLC 法同时测定补阳还五汤中毛蕊异 黄酮苷、芍药苷、羟基红花黄色素 A 的含量[J].中药新药与临床药理,2009,20(4):373-375.
[25] 李再新,吴小红,贺福元,等.大鼠血浆中补阳还五汤及总苷元的 阿魏酸药物动力学研究[J].中国药师,2007,10(10):943-945.
[26] 朱雪钦.基于Nrf2/ARE通路补阳还五汤化学成分及其抗MCAO药效机制研究[D].福州:福建中医药大学,2015.
[27] 许亮,陈春富.黄芪甲苷防治缺血性脑卒中的研究进展[J].中华老年心脑血管病杂志,2011,13(7):664-665.
[28] 苏蕾,范有明.黄芪甲苷对急性缺血性脑卒中神经保护作用研究进展[J].实用中医药杂志,2021,37(9):1619-1621.
[29] 李云波.通腑解毒法调节大鼠脑缺血/再灌注损伤后炎症反应及神经保护机制[J].中国实用医药,2013,8(22):264-266.
[30] 张洁.基于网络药理学的洋川芎内酯H治疗缺血性脑卒中的作用机制研究[D].扬州:扬州大学,2020.
[31] 林红.洋川芎内酯A对大鼠脑缺血再灌注损伤的保护作用研究[J].北方药学,2016,13(4):114-115.
[32] ZHANG Y,LI H,HUANG M,et al.Paeoniflorin a monoterpene glycoside protects the brain from cerebral ischemic injury via inhibition of apoptosis[J].The American Journal of Chinese Medicine,2015,43(3):543-557.
[33] ZHANG Y Q,QIAO L F,XU W,et al.Paeoniflorin attenuates cerebral ischemia-induced injury by regulating Ca2+/CaMKⅡ/CREB signaling pathway[J].Molecules,2017,22(3):359.
[34] SONG X B,LIU S H,QU X,et al.BMP2 and VEGF promote angiogenesis but retard terminal differentiation of osteoblasts in bone regeneration by up-regulating Id1[J].Acta Biochim Biophys Sin,2011,43(10):796-804.
[35] WILLEM S,YVES H,HARRY H,et al.VEGF-A and blood vessels:A beta cell perspective[J].Diabetologia,2019,62(11):1961-1968.
[36] ZHAO W,ZHAO L,LIAO J,et al.Early risk assessment of circulating endothelial progenitor cells and plasma stromal cell-derived factor-1 for nondisabling ischemic cerebrovascular events[J].BMC Neurol,2019,19(1):22.
[37] HUTCHISON S,SAHAY B,DEMELLO S C H,et al.Characterization of myeloid-derived suppressor cells and cytokines GM-CSF IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy[J].Vet Immunol Immunopathol,2019,216(2):109912.
[38] WANG Y,HAN G C,WANG K,et al.Tumor-derived GM-CSF promotes inflammatory colon carcinogenesis via stimulating epithelial release of VEGF[J].Cancer Res,2014,74(3):716-726.
[39] 潘满昌,林晓莹,汪虹,等.AMD3100联合G-CSF对2型糖尿病小鼠骨髓EPCs动员的培养[J].医学信息,2020,33(9):57-61.
[40] 祝慧凤,徐晓玉,万东,等.促红细胞生成素促脑血管新生机制研究进展[J].中国药理学通报,2011,27(4):451-454.
[41] 邓悦.G-CSF 与 EPO 对血管内皮祖细胞动员作用的对比研究[D].昆明:昆明医科大学,2012.
[42] CHRISTOPHER H,ALEXANDRA A,RALF L,et al.Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization[J].Blood,2003,102(4):1340-1346.
[43] CHEN M,WANG M,YANG Q,et al.Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-boswellic acid in combination on isoproterenol-induced myocardial injury in rats[J].International Journal of Molecular Medicine,2016,37(6):1501-1510.
[44] 谭燕萍.羟基红花黄色素-a与芍药苷对大鼠脑缺血再灌注损伤的保护作用及其对PI3K和AKT蛋白表达的影响[J].抗感染药学,2018,15(5):746-750.
相似文献/References:
[1]黄英媛,宋振华△,徐焕杰,等.补阳还五汤联合梅花针叩刺治疗脑梗死偏瘫疗效研究*[J].陕西中医,2020,(6):815.[doi:DOI:10.3969/j.issn.10007369.2020.06.033]
HUANG Yingyuan,SONG Zhenhua,XU Huanjie,et al.Clinical effect of Buyang Huanwu decoction combined with plum flower needle tapping on cerebral infarction hemiplegia[J].,2020,(7):815.[doi:DOI:10.3969/j.issn.10007369.2020.06.033]
[2]向宪文,刘西建.补阳还五汤联合经颅磁刺激治疗脑卒中后认知功能障碍临床研究*[J].陕西中医,2020,(7):885.[doi:DOI:10.3969/j.issn.10007369.2020.07.013]
[3]桂军明,朱守斌,张国旗,等.活血通络汤治疗痰瘀阻络型缺血性脑卒中临床研究*[J].陕西中医,2020,(8):1066.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.013]
GUI Junming,ZHU Shoubin,ZHANG Guoqi,et al.Clinical efficacy of Huoxue Tongluo decoction in the treatment of ischemic stroke of phlegm-stasis blocking collateral type[J].,2020,(7):1066.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.013]
[4]梁春玲,陈晓杰,刘祖发,等.补阳还五汤联合西药治疗急性脑梗死疗效及对患者血管斑块稳定性及血清因子水平的影响*[J].陕西中医,2020,(9):1200.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.006]
LIANG Chunling,CHEN Xiaojie,LIU Zufa,et al.Effect of Buyang Huanwu decoction combined with western medicine on stability of vascular plaque and serum factor levels in patients with acute cerebral infarction[J].,2020,(7):1200.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.006]
[5]田刘勤,陈 凯,陈 瑶.灯盏细辛治疗缺血性脑卒中疗效及对患者血清LPA、Hcy、MCP-1水平的影响*[J].陕西中医,2020,(11):1566.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]
TIAN Liuqin,CHEN Kai,CHEN Yao..Effects of erigeron breviscapus on levels of serum LPA,Hcy and MCP-1 in patients with ischemic stroke[J].,2020,(7):1566.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]
[6]刘 俊,华自森,李诚诚,等.补阳还五汤加伸筋草治疗脑梗死后痉挛型偏瘫疗效研究[J].陕西中医,2020,(12):1759.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.020]
LIU Jun,HUA Zisen,LI Chengcheng,et al.Efficacy study on Buyang Huanwu decoction with lycopodium clavatum on spastic hemiplegia after cerebral infarction[J].,2020,(7):1759.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.020]
[7]王红燕,朱卫华,刘小峰.补阳还五汤加减联合激光治疗糖尿病性黄斑水肿临床研究[J].陕西中医,2021,(7):896.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.022]
[8]张新波,郑 伟.补阳还五汤联合西药对面部缺损皮瓣修复术后恢复临床研究[J].陕西中医,2022,(4):461.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.012]
ZHANG Xinbo,ZHENG Wei.Effect of Buyang Huanwu decoction combined with western medicine in the treatment of facial defect skin flap repair[J].,2022,(7):461.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.012]
[9]韦茂英,赵琦瑶,高云逸,等.补阳还五汤联合西医治疗糖尿病脑病Meta分析[J].陕西中医,2022,(9):1310.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.040]
[10]李倩宇,卢健棋,温志浩,等.基于PI3K/Akt通路探讨补阳还五汤对急性心肌梗死大鼠内皮祖细胞凋亡的影响[J].陕西中医,2023,(7):827.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.001]
LI Qianyu,LU Jianqi,WEN Zhihao,et al.Effect of Buyang Huanwu prescription on apoptosis of endothelial progenitor cells in rats with acute myocardial infarction based on PI3K/Akt pathway[J].,2023,(7):827.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.001]